First Patient with Chronic Hepatitis B Dosed with ISA104 in First-in-Human Phase 1 Study
OEGSTGEEST, Netherlands, Aug. 31, 2023. ISA Pharmaceuticals B.V., a clinical-stage biotech company developing immunotherapies to treat cancers and serious infectious diseases, is pleased to announce that the first patient has been dosed in the... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - September 1, 2023 Category: Pharmaceuticals Source Type: clinical trials

The Role of Immune Semaphorins in Steatotic Liver Disease and Sepsis
Conditions:   Steatosis of Liver;   Sepsis;   Immune Response Interventions:   Diagnostic Test: Evaluation of the degree of steatosis;   Diagnostic Test: Screening for the components of metabolic syndrome;   Diagnostic Test: Measurement of serum semaphorin concentrations;   Diagnostic Test: Measurement of inflammatory cytokines Sponsors:   University Hospital for Infectious Diseases, Croatia;   Croatian Science Foundation Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 1, 2023 Category: Research Source Type: clinical trials